TotalSegmentator MRI is an open-source, user-friendly tool that provides automatic, robust sequence-independent segmentations of major anatomic structures on MRI scans; the ready-to-use online tool is available at https://totalsegmentator.com .
The purpose of this study was to assess whether habitus and organ enhancement influence iodine subtraction and should be incorporated into spectral subtraction algorithms.This study included 171 patients. In the unenhanced phase, MDCT was performed with single-energy acquisition (120 kVp, 250 mAs) and in the parenchymal phase with dual-energy acquisitions (80 kVp, 499 mAs; 140 kVp, 126 mAs). Habitus was determined by measuring trunk diameters and calculating circumference. Iodine subtraction was performed with input parameters individualized to muscle, fat, and blood ratio. Attenuation of the liver, pancreas, spleen, kidneys, and aorta was assessed in truly and virtually unenhanced image series. Pearson analysis was performed to correlate habitus with the input parameters. Analysis of truly unenhanced and virtually unenhanced images was performed with the Student t test; magnitude of variation was evaluated with Bland-Altman plots. Correction strategies were derived from organ-specific regression analysis of scatterplots of truly unenhanced and virtually unenhanced attenuation and implemented in a pixel-by-pixel approach. Analysis of individual organ correction and truly unenhanced attenuation was performed with the Student t test.The correlations between habitus and blood ratio (r = 0.694) and attenuation variation of fat at 80 kVp (r = -0.468) and 140 kV (r = -0.454) were confirmed. Although overall mean attenuation differed by no more than 10 HU between truly and virtually unenhanced scans overall, these differences varied by organ and were large in individual patients. Paired comparisons of truly and virtually unenhanced measurements differed significantly for liver, spleen, pancreas, kidneys, and aortic blood pool (p < 0.001 for all comparisons), but paired comparisons of truly unenhanced and individually organ-corrected measurements did not differ when organ- and habitus-based correction strategies were applied (p > 0.38 for all comparisons).Habitus and organ enhancement influence virtually unenhanced imaging and should be incorporated into spectral subtraction algorithms.
PURPOSE: To evaluate use of functional imaging with positron emission tomography (PET) versus computed tomography (CT) for detection of extranodal lymphoma spread. MATERIALS AND METHODS: Eighty-one consecutive and previously untreated patients with malignant non-Hodgkin lymphoma (n = 43) or Hodgkin disease (n = 38) were examined with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG) PET and contrast material-enhanced CT. Concordant findings at both CT and FDG PET were regarded as actual locations of disease; discordant results were resolved on the basis of biopsy or follow-up results when possible. RESULTS: Forty-two lesions were identified at both PET and CT, and 19 were verified with biopsy results. PET demonstrated a further 24 lesions. Verification was possible in 15 of these lesions with biopsy (n = 10), magnetic resonance imaging (n = 1), scintigraphic (n = 1), or follow-up (n = 3) results. In 14 of these 15 lesions, PET findings were confirmed (bone marrow, nine; spleen, three; other, two). Seven lesions not visualized at FDG PET were identified at CT, six of which were verified with biopsy (n = 2) or follow-up (n = 4) results. Five of these six CT findings were found to be erroneous. In 13 patients, PET findings led to changes in tumor staging. CONCLUSION: PET may provide more information about extranodal lymphoma than does incremental CT.
To examine patients with advanced cardiovascular disease with radiology after indirect myocardial revascularization with a free-skeletal-muscle transplant and to determine whether the attached vessel remains patent over the middle and long terms.In 10 patients with advanced, inoperable cardiovascular disease treated with indirect myocardial revascularization with a free-muscle transplant, radiologic follow-up was performed postoperatively and every 6 months. All 10 patients underwent selective arteriography of the anastomosed vessel and contrast material-enhanced helical computed tomography (CT) (transverse sections and reconstructions).All patients showed adequate vascular conditions postoperatively, as did nine of 10 patients after 1 year. In one patient, the anastomosed artery was occluded. CT showed time-dependent muscle degeneration in all patients. Postoperative, contrast-enhanced, superselective CT showed an area of high-attenuating uptake in the muscle transplant in all patients. After 1 year, CT depicted perfusion defects of the skeletal muscle in two patients. In eight patients, however, small vascular bridges from the skeletal muscle to the myocardium were detected. Radiologic results correlated well with clinical outcome and stress electrocardiograms.Helical intraarterial CT and arteriography were sensitive in depicting enhancement and remaining vital function in nine of 10 patients after indirect myocardial revascularization with a free-muscle transplant. This combination seems promising for postoperative examination in such patients.
